Rights and permissions
About this article
Cite this article
Galantamine worth it for AD in many countries. Pharmacoecon. Outcomes News 462, 5 (2004). https://doi.org/10.2165/00151234-200404620-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200404620-00007